Andreja Rehberger Likozar

Influence of trimetazidine and ranolazine on endothelial function in patients with ischemic heart disease

Andreja Rehberger Likozar, Miran Šebeštjen · Coronary Artery Disease · 2015 · 21 citations

Influence of lipid-lowering drugs on inflammation: what is yet to be done?

Sabina Ugovšek, Janja Zupan, Andreja Rehberger Likozar et al. · Archives of Medical Science · 2021 · 16 citations · Full text

Hyperlipidemia, Pharmacotherapy, Residual Inflammation +17

Interplay between microRNAs, Serum Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9), and Lipid Parameters in Patients with Very High Lipoprotein(a) Treated with PCSK9 Inhibitors

Tina Levstek, Tina Karun, Andreja Rehberger Likozar et al. · Genes · 2023 · 14 citations · Full text

The Influence of Treatment with PCSK9 Inhibitors and Variants in the CRP (rs1800947), TNFA (rs1800629), and IL6 (rs1800795) Genes on the Corresponding Inflammatory Markers in Patients with Very High Lipoprotein(a) Levels

Tina Levstek, Nik Podkrajšek, Andreja Rehberger Likozar et al. · Journal of Cardiovascular Development and Disease · 2022 · 13 citations · Full text

LPA Genotypes and Haplotypes Are Associated with Lipoprotein(a) Levels but Not Arterial Wall Properties in Stable Post-Coronary Event Patients with Very High Lipoprotein(a) Levels

Andreja Rehberger Likozar, Aleš Blinc, Katarina Trebušak Podkrajšek et al. · Journal of Cardiovascular Development and Disease · 2021 · 11 citations · Full text